Percutaneous absorption of pimecrolimus is not increased in patients with moderate to severe atopic dermatitis when pimecrolimus cream 1% is applied under occlusion.
Tools
Thaçi, Diamant, Kaufmann, Roland, Bieber, Thomas, Hanfland, Julia, Hauffe, Suzanne, Koehne-Voss, Stephan and Waldmeier, Felix (2010) Percutaneous absorption of pimecrolimus is not increased in patients with moderate to severe atopic dermatitis when pimecrolimus cream 1% is applied under occlusion. Dermatology (Basel, Switzerland), 221 (4). pp. 342-351. ISSN 1421-9832
Official URL: http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retri...
Abstract
To evaluate the systemic exposure of pimecrolimus cream 1% applied under occlusion in atopic dermatitis (AD) patients.
Item Type: | Article |
---|---|
Date Deposited: | 31 Jan 2012 00:45 |
Last Modified: | 01 Feb 2013 00:45 |
URI: | https://oak.novartis.com/id/eprint/6606 |